Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17‐beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms

HIGHLIGHTS

• who: | and colleagues from the Newcastle National Institute for Research Centre/Newcastle University have published the research work: Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17u2010beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms, in the Journal: (JOURNAL)

SUMMARY

@@

ACRONYMS

LAY DEFINITIONS

• hydroxysteroid: A hydroxysteroid is a molecule derived from a steroid with a hydrogen replaced with a hydroxy group. When the hydroxy group is specifically at the C3 position, hydroxysteroids are referred to as . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.